cNeuro

cNeuro® platform provides tools for helping to interpret your data in neurology. cMRI is a tool for quantitative assessment of brain images providing insights to imaging data in neurological disorders.cDSI is a tool for clinical decision support in dementia with the combination of imaging, lab results, and clinical data. cNeuro uses cutting-edge technology to help physicians to interpret more precisely complex patient data.The software supports decision making and communication between radiologists and referring physicians.

The cloud-based AI software is possible to integrate seamlessly with hospital systems to assist in the accurate and consistent quantitative evaluation.

cNeuro® IS MADE FOR YOU IF

  • You want to get your images interpreted more consistently and objectively.
  • You want to exploit the data already acquired more
    comprehensively.
  • You want to improve communication with your patients
    and your colleagues.
  • You want to always have an up to date version in hand through a cloud service.
  • You are interested in neurodegenerative diseases.

Features

cMRI

What it does:

  • Quantifies 133 regions from T1 images and white-matter hyperintensities from FLAIR images.
  • Computes specific imaging biomarkers for neurodegenerative diseases.
  • Compares to normative data.
  • Enables interactive review.
  • Generates a summary report for streamlined communication.
  • Corrects quantitative information for age, gender and head size.

User: Radiologist (& Referring physician).

Reimbursement (US): CPT-code 76377, ”3D volume measurement” order required.

Product status: CE marked and FDA 510(k) cleared.

cDSI

What it does:

Combines all patient data and compares to a large database of previously diagnosed patients:

  • Predicts progression.
  • Aids in the differential diagnosis.
  • Gives a compact and intuitive overview of all data.

Data sources supported:

  • Clinical and neuropsychological tests: MMSE, RAVLT/CERAD recall & delayed recall, TMT A&B, Animal fluency, NPI.
  • MRI imaging biomarkers from cMRI: volume (US and EU versions) and computed MTA, GCA (global and local), Fazekas (EU version).
  • Biomarkers: CSF biomarkers, APOE.

User: Referring physician (& radiologist).

Product status: CE marked and excluded from the definition of a medical device in the U.S., based on section 520(o)(1)(e) of the Food Drug and Cosmetic Act.
U.S Patent No. 7,840,510

Tuija Itkonen
Sales Manager, HR
+358 40 835 5884
tuija.itkonen@mediconnection.fi

Ahmed Mahdi
International Sales/Marketing
+358 50 477 2009
ahmed.mahdi@mediconnection.fi

Insights

cNeuro

cNeuro® platform provides tools for helping to interpret your data in neurology. cMRI is a tool for quantitative assessment of brain images providing insights to imaging data in neurological disorders.cDSI is a tool for clinical decision support in dementia with the combination of imaging, lab results, and clinical data. cNeuro uses cutting-edge technology to help physicians to interpret more precisely complex patient data.The software supports decision making and communication between radiologists and referring physicians.

The cloud-based AI software is possible to integrate seamlessly with hospital systems to assist in the accurate and consistent quantitative evaluation.

cNeuro® IS MADE FOR YOU IF

  • You want to get your images interpreted more consistently and objectively.
  • You want to exploit the data already acquired more
    comprehensively.
  • You want to improve communication with your patients
    and your colleagues.
  • You want to always have an up to date version in hand through a cloud service.
  • You are interested in neurodegenerative diseases.

Features

cMRI

What it does:

  • Quantifies 133 regions from T1 images and white-matter hyperintensities from FLAIR images.
  • Computes specific imaging biomarkers for neurodegenerative diseases.
  • Compares to normative data.
  • Enables interactive review.
  • Generates a summary report for streamlined communication.
  • Corrects quantitative information for age, gender and head size.

User: Radiologist (& Referring physician).

Reimbursement (US): CPT-code 76377, ”3D volume measurement” order required.

Product status: CE marked and FDA 510(k) cleared.

cDSI

What it does:

Combines all patient data and compares to a large database of previously diagnosed patients:

  • Predicts progression.
  • Aids in the differential diagnosis.
  • Gives a compact and intuitive overview of all data.

Data sources supported:

  • Clinical and neuropsychological tests: MMSE, RAVLT/CERAD recall & delayed recall, TMT A&B, Animal fluency, NPI.
  • MRI imaging biomarkers from cMRI: volume (US and EU versions) and computed MTA, GCA (global and local), Fazekas (EU version).
  • Biomarkers: CSF biomarkers, APOE.

User: Referring physician (& radiologist).

Product status: CE marked and excluded from the definition of a medical device in the U.S., based on section 520(o)(1)(e) of the Food Drug and Cosmetic Act.
U.S Patent No. 7,840,510

Tuija Itkonen
Sales Manager, HR
+358408355884
tuija.itkonen@mediconnection.fi

Ahmed Mahdi
International Sales/Marketing
+358504772009
ahmed.mahdi@mediconnection.fi

Insights